StonvexLoading…
StonvexStonvexStonvexCore line items from CPOP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $107.63M | $47.38M | $18.54M | $32.28M |
Operating Income | $-6.37M | $-13.64M | $-24.42M | $1.42M |
Net Income | $-6.89M | $-12.41M | $-24.33M | $787.96K |
EPS (Diluted) | $-0.49 | $-4.32 | $-10.10 | $0.40 |
Total Assets | $114.88M | $42.23M | $39.05M | $64.37M |
Total Liabilities | $93.27M | $26.91M | $12.87M | $11.60M |
Cash & Equivalents | $2.61M | $230.56K | $2.75M | $14.40M |
Free Cash Flow OCF − CapEx | $180.27K | $-5.17M | $-6.59M | $-11.46M |
Shares Outstanding | 14.14M | 2.87M | 2.41M | 2.10M |